205 related articles for article (PubMed ID: 25801471)
1. The compensatory renin-angiotensin system in the central regulation of arterial pressure: new avenues and new challenges.
Mendoza A; Lazartigues E
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):201-8. PubMed ID: 25801471
[TBL] [Abstract][Full Text] [Related]
2. Brain angiotensin-converting enzyme type 2 shedding contributes to the development of neurogenic hypertension.
Xia H; Sriramula S; Chhabra KH; Lazartigues E
Circ Res; 2013 Oct; 113(9):1087-1096. PubMed ID: 24014829
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: a positive feedback mechanism in the RAS.
Patel VB; Clarke N; Wang Z; Fan D; Parajuli N; Basu R; Putko B; Kassiri Z; Turner AJ; Oudit GY
J Mol Cell Cardiol; 2014 Jan; 66():167-76. PubMed ID: 24332999
[TBL] [Abstract][Full Text] [Related]
4. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
5. ACE2 and ADAM17 Interaction Regulates the Activity of Presympathetic Neurons.
Mukerjee S; Gao H; Xu J; Sato R; Zsombok A; Lazartigues E
Hypertension; 2019 Nov; 74(5):1181-1191. PubMed ID: 31564162
[TBL] [Abstract][Full Text] [Related]
6. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
Krum H; Gilbert RE
J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-(1-7) as a strategy in the treatment of hypertension?
van Twist DJ; Kroon AA; de Leeuw PW
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):480-6. PubMed ID: 25023950
[TBL] [Abstract][Full Text] [Related]
8. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
Henriksen EJ; Prasannarong M
Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
[TBL] [Abstract][Full Text] [Related]
9. [The ACE2/Ang(1-7)/Mas receptor axis in cardiovascular and renal diseases].
Kanda T; Itoh H
Nihon Rinsho; 2012 Sep; 70(9):1487-91. PubMed ID: 23012792
[TBL] [Abstract][Full Text] [Related]
10. Clinical Relevance and Role of Neuronal AT
Xu J; Sriramula S; Xia H; Moreno-Walton L; Culicchia F; Domenig O; Poglitsch M; Lazartigues E
Circ Res; 2017 Jun; 121(1):43-55. PubMed ID: 28512108
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II downregulates ACE2-mediated enhancement of MMP-2 activity in human cardiofibroblasts.
Kuan TC; Chen MY; Liao YC; Ko L; Hong YH; Yen CY; Hsieh WY; Cheng KS; Wu CL; Lin CS
Biochem Cell Biol; 2013 Dec; 91(6):435-42. PubMed ID: 24219285
[TBL] [Abstract][Full Text] [Related]
12. [The Protective Arm of Renin Angiotensin System; Recent Research Progress and Expectation for New Therapeutic Approach].
Horiuchi M
Nihon Rinsho; 2016 Sep; 74(9):1583-1589. PubMed ID: 30557497
[TBL] [Abstract][Full Text] [Related]
13. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
14. [Effect of tanshinone II(A) on expression of different components in renin-angiotensin system of left ventricles of hypertensive rats].
Yu LZ; Shi CR
Zhongguo Zhong Yao Za Zhi; 2014 Apr; 39(8):1468-72. PubMed ID: 25039184
[TBL] [Abstract][Full Text] [Related]
15. Peptides as targets for antihypertensive drug development.
Hedner T; Sun X; Junggren IL; Pettersson A; Edvinsson L
J Hypertens Suppl; 1992 Dec; 10(7):S121-32. PubMed ID: 1291647
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of reactive oxygen species in hypothalamic paraventricular nucleus attenuates the renin-angiotensin system and proinflammatory cytokines in hypertension.
Su Q; Qin DN; Wang FX; Ren J; Li HB; Zhang M; Yang Q; Miao YW; Yu XJ; Qi J; Zhu Z; Zhu GQ; Kang YM
Toxicol Appl Pharmacol; 2014 Apr; 276(2):115-20. PubMed ID: 24576725
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Regulation of the Local Renin-Angiotensin System in the Myocardium of Spontaneously Hypertensive Rats by Feeding Bioactive Peptides Derived from Spirulina platensis.
Pan H; She X; Wu H; Ma J; Ren D; Lu J
J Agric Food Chem; 2015 Sep; 63(35):7765-74. PubMed ID: 26245714
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of angiotensin converting enzyme 2 and nuclear factor-κB by angiotensin II receptor subtypes in type 2 diabetic kidney.
Pandey A; Goru SK; Kadakol A; Malek V; Gaikwad AB
Biochimie; 2015 Nov; 118():71-81. PubMed ID: 26271886
[TBL] [Abstract][Full Text] [Related]
20. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
